Episode 14: Trends in the Alzheimer Clinical Pipeline

July 31, 2020
Matt Hoffman
Matt Hoffman

Matt Hoffman, Senior Editor for NeurologyLive, has covered medical news for MJH Life Sciences, NeurologyLive’s parent company, since 2017. He hosts the NeurologyLive Mind Moments podcast, as well as Second Opinion on Medical World News. Follow him on Twitter @byMattHoffman or email him at mhoffman@neurologylive.com

"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Jeffrey Cummings, MD, ScD.

Jeffrey Cummings, MD, ScD

Episode 14 of the NeurologyLive Mind Moments podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.

The Mind Moments podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.

Episode 14, "Trends in the Alzheimer Clinical Pipeline," features an interview with Jeffrey Cummings, MD, ScD, director emeritus, Lou Ruvo Center for Brain Health, Cleveland Clinic, and vice-chair, Department of Brain Health, University of Nevada—Las Vegas. He shared his insight into a recent review he and colleagues did of the trends in the Alzheimer Disease pipeline and what he expects for the future of the disease's care.

Click here to subscribe to the Mind Moments podcast. Thanks for listening!